🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Singapore / NCT07532551
Recruiting Not applicable

Internet-Based Cognitive Behavioural Therapy (iCBT) for Anxiety and Depression in Singapore

NCT07532551 · tracked via the Priya Life Science Singapore tracker
Phase
Not applicable
Started
2026-07-02
Last updated
2026-08-05

Condition(s) studied

Depression and/or Anxiety in the Mild-to-moderate RangeCognitive Behavioral Therapy

Investigational drug(s) / intervention(s)

Internet-delivered cognitive behavioural therapy (iCBT)

Internet-delivered cognitive behavioural therapy (iCBT): Guided iCBT in Singapore for mild-to-moderate anxiety and/or depression

Study summary

Cognitive-behavioural therapy (CBT) has a robust evidence base for treating anxiety disorders and depression, including transdiagnostic CBT. Internet-based CBT (iCBT) offers a new approach to delivering these therapies. iCBT is a digital adaptation of traditional CBT that leverages digital platforms to deliver similar therapeutic interventions. iCBT encompasses structured programmes that provide users with tools and techniques to manage mental health issues such as depression and anxiety. The digital format ensures timely access to CBT and typically includes interactive modules, videos, self-assessment tools, and virtual therapist support. This study aims to evaluate the effectiveness of iCBT in reducing symptoms of anxiety and depression, as well as its cost-effectiveness and acceptability in local context.

The main questions it aims to answer are:

1. Do participants receiving iCBT show a reduction in symptoms of anxiety and/or depression, and does the effectiveness of iCBT vary based on individual user characteristics?
2. What are the factors that influence the acceptance, adoption, and engagement rates of iCBT among Singaporeans?
3. Is iCBT more cost-effective as compared to usual care?

Researchers will compare guided iCBT to usual care (traditional CBT) to assess iCBT's clinical effectiveness, cost-effectiveness, and acceptability in Singapore's primary and community healthcare settings.

Participants in the intervention group will:

1. Undergo guided iCBT intervention consisting of 8 weeks of online modules covering core CBT techniques
2. Counsellors will schedule 3 regular check-ins
3. Questionnaires will be administered at 5 timepoints
4. Selected participants will be invited for a semi-structured interview to assess their experiences with iCBT

Participants in the control group will:

1. Continue usual care
2. Questionnaires will be administered at 5 timepoints

A parallel qualitative study involving service providers is required to contextualise trial findings, identify implementation barriers and enablers and inform national scale-up and policy decisions. It aims to explore service providers' experiences, perceptions and contextual factors influencing the implementation of iCBT within routine primary-care and community mental-health services participating in this trial.

Eligibility

Sex
ALL
Min age
21 Years
Max age
—
Healthy volunteers
No
1. Quantitative Study - Patients Inclusion Criteria: * Age ≥21 years * Tier 2 - 3 depression and/or anxiety based on PHQ-9 and GAD-7 scores * PHQ-9 score of 5 to 19 * GAD-7 score of 5 to 14 * Able to provide informed consent Exclusion Criteria: * Unable to read or understand English (Primary 6 level) * Unable to use the internet (e.g. due to lack of internet access or insufficient digital literacy) * Does not possess a mobile device or is not able to access the iCBT application * Actively experiencing psychosis * Suspected with personality disorder * Primary concern is obsessive compulsive disorder (OCD) * Tier 4 patients with severe depression or anxiety * PHQ-9 score of 20 and above * GAD-7 score of 15 and above * Any suicidal risk or ideation * PHQ-9 Question 9 score of more than 2 2. Qualitative Study - Service Providers Inclusion Criteria: * Are currently or previously have been involved in the delivery, supervision, or implementation of the iCBT programme * Have had direct experience supporting patients enrolled in the study * Able to provide informed consent Exclusion Criteria: * Have no direct involvement in the iCBT programme; or * Have had insufficient exposure to the programme, defined as managing fewer than one referred case or less than one month of involvement at the time of recruitment. * Conflict of interest or Supervisory Hierarchy Concerns - Individuals whose participation may create perceived coercion or introduce bias * Inability to provide informed consent

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
[Viriya] Mental Wellness Hub Singapore Singapore Recruiting
[Allkin] Integrated Service Centre @ Sengkang 193 Singapore Singapore Recruiting
[Fei Yue] Family Service Centre (Choa Chu Kang) Singapore Singapore Recruiting

More National University of Singapore trials in Singapore

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07532551 on ClinicalTrials.gov ↗ ← All trials in Singapore